Patents Assigned to EUPHARMA PTY LTD
  • Arsenic compositions
    Patent number: 11241453
    Abstract: The present invention is predicated on the realisation that problems with the poor water solubility of arsenic trioxide and the extreme difficulty in dissolving arsenic trioxide in anything other than a very basic solution, could be overcome by forming a much more soluble diarsenic tetraoxide, including the compound NaHAs2O4, prior to its delivery to a patient. Pharmaceutical compositions with such compounds and their use in the treatment of cancers is disclosed.
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: February 8, 2022
    Assignee: Eupharma Pty Ltd
    Inventor: Malvin Eutick
  • Compositions containing arsenic and their use in methods of treatment
    Patent number: 10493099
    Abstract: A pharmaceutical composition is provided comprising a highly soluble arsenic carbonate and/or bicarbonate compound and which is useful in the treatment of a variety of cancers, including acute promyelocytic leukaemia. The arsenic carbonate and/or bicarbonate salt acts as a solid, and so orally deliverable, improved bioequivalent delivery form of arsenic trioxide IV solutions.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: December 3, 2019
    Assignee: EUPHARMA PTY LTD
    Inventor: Malvin Eutick
  • Process for the purification of diaminophenothiazinium compounds
    Patent number: 10160735
    Abstract: A process for the purification of diaminophenothiazinium compounds, and particularly of methylene blue, is described. The process provides for simple and effective purification by reduction of the post-synthesis or commercially available diaminophenothiazinium compound to form a reduced complex thereof. This can then be purified in a more straightforward manner than the original compound by, for example, recrystallization before being allowed to oxidize back to the diaminophenothiazinium compound.
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: December 25, 2018
    Assignee: Eupharma Pty Ltd
    Inventor: Malvin Eutick
  • Ruthenium and Indium Binding to Gastrins
    Publication number: 20180021373
    Abstract: The present invention relies on the hitherto unrealised high affinity binding of ruthenium and indium to gastrins. Particularly, these metals can be bound directly to the gastrins under mild conditions and so can be used in treatment of conditions associated with elevated gastrin levels and in detection of tumours and other conditions where CCK receptors are over expressed.
    Type: Application
    Filed: February 4, 2016
    Publication date: January 25, 2018
    Applicant: Eupharma Pty Ltd
    Inventor: Malvin EUTICK
  • Process for the purification of diaminophenothiazinium compounds
    Patent number: 9701648
    Abstract: A process for the purification of diaminophenothiazinium compounds, and particularly of methylene blue, is described. The process provides for simple and affective purification by reduction of the post-synthesis or commercially available diaminophenothiazinium compound to form a reduced complex thereof. This can then be purified in a more straightforward manner than the original compound by, for example, recrystallization before being allowed to oxidize back to the diaminophenothiazinium compound.
    Type: Grant
    Filed: August 15, 2014
    Date of Patent: July 11, 2017
    Assignee: Eupharma Pty Ltd
    Inventor: Malvin Eutick
  • Viscous haemostatic compositions and method of treatment
    Patent number: 9522214
    Abstract: A method of promoting haemostasis in a patient is provided by the administration, to the site of blood loss, of a viscous thixotropic haemostatic composition comprising an ionic precipitating agent, a fatty alcohol, an alcohol phosphate diester and one of an alkoxyether phosphate or a monoester phosphate of an alkoxylated fatty alcohol.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: December 20, 2016
    Assignee: Eupharma PTY LTD
    Inventor: Malvin Eutick
  • VISCOUS HAEMOSTATIC COMPOSITIONS AND METHOD OF TREATMENT
    Publication number: 20150238652
    Abstract: A method of promoting haemostasis in a patient is provided by the administration, to the site of blood loss, of a viscous thixotropic haemostatic composition comprising an ionic precipitating agent, a fatty alcohol, an alcohol phosphate diester and one of an alkoxyether phosphate or a monoester phosphate of an alkoxylated fatty alcohol.
    Type: Application
    Filed: September 12, 2013
    Publication date: August 27, 2015
    Applicant: Eupharma Pty Ltd
    Inventor: Malvin Eutick
  • Oral Composition Comprising An Antacid, an Anaesthetic and an Inorganic Matrix Comprising Silicon Dioxide and Titanium Dioxide
    Publication number: 20140141087
    Abstract: The invention provides an oral composition comprising a pharmaceutically acceptable carrier, at least one antacid, an inorganic matrix comprising at least silicon dioxide and titanium dioxide, and an anaesthetic, wherein the composition is substantially evenly dispersed in the carrier and is palatable.
    Type: Application
    Filed: July 13, 2012
    Publication date: May 22, 2014
    Applicant: Eupharma Pty Ltd
    Inventor: Malvin Eutick
  • RADIATION SENSITISER COMPOSITIONS
    Publication number: 20130096123
    Abstract: The invention provides an oral liquid composition of a hypoxic radiation sensitiser comprising the radiation sensitiser in a concentration of greater than 5 mg/ml, and a method of treating a subject with a hypoxic condition comprising administration to the subject of a combination of a composition of the invention and radiation.
    Type: Application
    Filed: April 14, 2011
    Publication date: April 18, 2013
    Applicant: EUPHARMA PTY LTD
    Inventor: Malvin Leonard Eutick